Cargando…

Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials

Fibrous septae play a role in contour alterations associated with cellulite. OBJECTIVE: To assess collagenase clostridium histolyticum-aaes (CCH) for the treatment of cellulite. MATERIALS AND METHODS: Two identically designed phase 3, double-blind, randomized studies (RELEASE-1 and RELEASE-2) were c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaufman-Janette, Joely, Joseph, John H., Kaminer, Michael S., Clark, James, Fabi, Sabrina G., Gold, Michael H., Goldman, Mitchel P., Katz, Bruce E., Peddy, Kappa, Schlessinger, Joel, Young, V. Leroy, Davis, Matthew, Hurley, David, Liu, Genzhou, McLane, Michael P., Vijayan, Saji, Bass, Lawrence S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078112/ https://www.ncbi.nlm.nih.gov/pubmed/33840781 http://dx.doi.org/10.1097/DSS.0000000000002952

Ejemplares similares

Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
por: Bass, Lawrence S., et al.
Publicado: (2022)

Efficacy, Safety, and Durability of Response of Collagenase Clostridium Histolyticum-aaes for Treating Cellulite
por: Kaufman-Janette, Joely A., et al.
Publicado: (2020)

Evaluation of five collagenase clostridium histolyticum‐aaes injection techniques for the treatment of cellulite on the buttock or thigh
por: Kaufman‐Janette, Joely, et al.
Publicado: (2022)

Collagenase Clostridium Histolyticum for the Treatment of Edematous Fibrosclerotic Panniculopathy (Cellulite): A Randomized Trial
por: Sadick, Neil S., et al.
Publicado: (2019)

Characterization of Tissue Histology for the Injectable Cellulite Treatment Collagenase Clostridium Histolyticum-aaes: Results in Swine
por: Shridharani, Sachin M, et al.
Publicado: (2023)

New Considerations in the Use of Collagenase Clostridium Histolyticum for the Treatment of Cellulite
por: Grekin, Jeremy A, et al.
Publicado: (2023)

Evaluation of alternative diluents for clinical use of collagenase clostridium histolyticum (CCH‐aaes)
por: Wolfe, Henry R., et al.
Publicado: (2021)

Real-World Experience With Collagenase Clostridium Histolyticum-aaes for Buttock and Thigh Cellulite: Focus on Administration and Safety Profile
por: Shridharani, Sachin M, et al.
Publicado: (2023)

Enzymatic Subcision and Remodeling after Collagenase Clostridium histolyticum-Aaes Subcutaneous Injection: Updated Evidence from Porcine and Human Studies
por: Sachin, Shridharani, et al.
Publicado: (2021)

Collagenase Clostridium histolyticum for the Treatment of Cellulite in the Buttocks and Thigh: Early Insights From Clinical Practice
por: Graivier, Miles, et al.
Publicado: (2022)

Insights Into the Pathophysiology of Cellulite: A Review
por: Bass, Lawrence S., et al.
Publicado: (2020)

Development and Validation of the Clinician Reported and Patient Reported Photonumeric Scales to Assess Buttocks Cellulite Severity
por: Cohen, Joel L., et al.
Publicado: (2020)

Role of collagenase clostridium histolyticum in Peyronie’s disease
por: Peak, Taylor C, et al.
Publicado: (2015)

Study of a New Controlled Focal Septa Release Cellulite Reduction Method
por: Stevens, W Grant, et al.
Publicado: (2022)

Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020)

Monitoring the Degradation of Collagen Hydrogels by Collagenase Clostridium histolyticum
por: Ng, Hon Wei, et al.
Publicado: (2020)

The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States
por: Sun, Andrew J., et al.
Publicado: (2019)

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)

Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015)

Collagenase Clostridium histolyticum : emerging practice patterns and treatment advances
por: Warwick, David, et al.
Publicado: (2016)

Effectiveness of different molecular forms of C. histolyticum class I collagenase to recover islets
por: Green, Michael L., et al.
Publicado: (2017)

Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Intralesional collagenase clostridium histolyticum study provides real-world analysis
por: Haney, Nora M., et al.
Publicado: (2016)

Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
por: Kuhlmann, Paige K, et al.
Publicado: (2017)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012)

Retraction: Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

AB041. Experience in the use of collagenase clostridium histolyticum in the management of Peyronie’s disease
por: Jad, Amr, et al.
Publicado: (2016)

Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017)

Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up
por: Nayar, Suresh K., et al.
Publicado: (2019)

Peyronie’s disease – outcomes of collagenase clostridium histolyticum injection: A systematic review
por: Mefford, Austin T., et al.
Publicado: (2021)

Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
por: Gannon, Margaret K., et al.
Publicado: (2021)

Incidence of Tendon Rupture After Collagenase Clostridium Histolyticum Injection for Treatment of Dupuytren Contracture in Adults: A Postmarketing Safety Analysis
por: Peimer, Clayton A., et al.
Publicado: (2022)

Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie’s disease
por: Diao, Linley, et al.
Publicado: (2017)

Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017)

Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017)

Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie’s disease
por: Aliperti, Louis A., et al.
Publicado: (2017)

Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: An Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2022)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
por: Noto, Kimitoshi, et al.
Publicado: (2019)

Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren’s Deformity Correction
por: Kasture, Sarang, et al.
Publicado: (2021)

Improvement in the ability to have sex in patients with Peyronie's disease treated with Collagenase Clostridium histolyticum
por: Geelhoed, Jeannette P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d37hpng3tcrd4tv01vgiqjdem9